Mutation in SIV-PBj Nef Protein Prevents Disease in Macaques
Author Information
Author(s): Tschulena Ulrich, Sanzenbacher Ralf, Mühlebach Michael D, Berger André, Münch Jan, Schindler Michael, Kirchhoff Frank, Plesker Roland, Coulibaly Cheick, Panitz Sylvia, Prüfer Steffen, Muckenfuss Heide, Hamdorf Matthias, Schweizer Matthias, Cichutek Klaus, Flory Egbert
Primary Institution: Paul-Ehrlich-Institut
Hypothesis
Does mutation of a diacidic motif in SIV-PBj Nef affect T-cell activation and disease progression?
Conclusion
Mutating the diacidic motif in the PBj-Nef protein stops disease progression in pig-tailed macaques while allowing efficient viral replication.
Supporting Evidence
- Mutant PBj-Nef202/203GG did not induce enteropathic complications in macaques.
- Both wild-type and mutant viruses replicated efficiently in macaque PBMCs.
- PBj-Nef202/203GG infection resulted in reduced T-cell activation compared to wild-type PBj.
Takeaway
Changing a tiny part of a virus can stop it from making animals sick, even though the virus can still grow well.
Methodology
The study involved infecting pig-tailed macaques with either wild-type or mutant SIV-PBj and analyzing their immune responses and disease symptoms.
Potential Biases
Potential bias in interpreting results due to the small sample size and specific focus on one mutation.
Limitations
The study was limited to a small number of macaques and focused on a specific viral mutation.
Participant Demographics
Pig-tailed macaques (Macaca nemestrina) were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website